NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Biopsy



Studies in the area of biopsy reported from Aarhus University



January 15th, 2008

In this recent article published in the journal Gynecologic Oncology, scientists in Aarhus, Denmark conducted a study "To investigate the effect of topical imiquimod in patients with vulvar intraepithelial neoplasia, (VIN). We used a prospective, randomised, double-blinded, placebo-controlled study."

"Women with biopsy verified, visible VIN2 or VIN3, in a biopsy not older than 2 months were considered. Thirty-two patients were included, one was excluded before treatment. Twenty-one received active treatment, 10 received placebo. Seventeen (81%) in the treatment group showed complete response, two (10%) partial response and none responded in the placebo-group...


Source: Cancer Weekly (2008-01-15)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login